Loading…
The Travelers Companies, Inc.
NYSE: TRV Financials Insurance 🔎 Screen
Dow 30 S&P 500
🏹 Trader: 🚀 Stage 2 + Near High 📈 Stage 2 🎯 Near 52W High | BRS 76 Ready View all →
📈 Stage 2 detected Find the fundamental catalyst → → run Growth Triggers in Ask AI
$81.4B
Market Cap
10.6
P/E
2.64
PEG
21.8%
ROCE
20.7%
ROE
D/E
16.8%
OPM
-6.9%
% from 52W High
79
α RS
🔍 TRV is showing a high-conviction setup because it matches 10 of 37 tracked screener presets, RS Rating is 79, and an ECS of 58.4 last quarter. Net: Broad signal stack, not a recommendation. ? Conviction RS Rating ECS
Sources
Conviction 10/37 · RS Rating 79 · ECS 58.4
⚖️ Compare 🔒 Generate Report 🔒 Research Packet 📚 Guides
🌏 Global Investor Returns
Currency-adjusted total returns for TRV including FX impact
🌏
Click 🌏 Returns tab to load data
📈 Price History
Ratio Health
Excellent
Good
Average
Poor
By Category
📊 Sector Averages
About

The Travelers Companies, Inc., through its subsidiaries, provides a range of commercial and personal property, and casualty insurance products and services to businesses, government units, associations, and individuals in the United States, Canada, and internationally.

Key Ratios Snapshot
📈 Growth Pattern
📊 Quick Scorecard
Loading…
🔒
Premium Feature
AI-generated 10-section company profile — business model, financials, strengths, risks & management quality
Upgrade to Premium
Already a member? Log in
📐
3-Statement Financial Model
Bear / Base / Bull projections · DCF fair value · Reverse-DCF
Open Model →
🎙 Management Tone Confident Specific → Stable 5 quarters Full tone analysis in Intelligence →
Good quarter Investor Presentation One-Pager? Q2 2026
Revenue
$12.153B
+0.3% YoY
Operating Income
$2.160B
+44% YoY
Operating Margin
16.4%
+6.7pp YoY
Net Income
$2.208B
+46% YoY
What Went Right
  • Core income rose 44% to $2.160B, or $10.04 per diluted share, with core ROE of 24.9% and trailing four-quarter core ROE of 24.2%.
  • Combined ratio improved 6.7 points to 83.6% and underlying combined ratio improved to 84.1%, driven by a lower underlying loss ratio across all three segments.
  • After-tax net investment income increased 14% to $883M, and more than $1.5B of capital was returned to shareholders, including $1.3B of buybacks.
What to Watch
  • Business Insurance national property premiums declined as underwriting discipline is maintained; property renewal pricing is softening, led by national and large scheduled property.
  • Personal auto renewal premium change was flat and market-level rate decreases persist, limiting near-term growth despite healthy new business and strong margins.
  • Expense ratio ticked up to 29% due to higher profit-sharing and contingent commission costs, and management acknowledged a technology/system conversion issue caused some customer and agent disruption.
Management Guidance
  • Full-year 2026 expense ratio expected to remain around 28.5%.
  • Fixed income NII expected to be approximately $840M in Q3 and $870M in Q4, with continued growth expected beyond 2026.
  • No explicit revenue guidance; management expects continued strong premium levels at attractive underlying margins.
Investor Lens
The investment thesis is stronger after this quarter. Travelers delivered a 24.9% core ROE with another $1.3B after-tax underlying underwriting quarter, growing net investment income, and $578M of favorable prior-year development. Capital returns remain robust, with adjusted book value per share up 16% year over year. The main cautions are modest softening in Business Insurance property and competitive personal auto pricing, but management is holding discipline and focusing on franchise value rather than price.
From investor presentation · AI-generated analysis · Not investment advice
🔒
Premium Feature
Investor Presentation One-Pager — quarterly highlights, what went right/wrong & management guidance
Upgrade to Premium
Already a member? Log in
📈 STRONG Excellent quarter: core ROE 24.9%, combined ratio 83.6%.
Revenue
Total revenues were $12.153B, roughly flat year over year. Net written premiums were $11.529B, with Business Insurance up 5% adjusting for Canada sale, Bond & Specialty up 14% to $1.2B, and Personal Insurance at $4.3B.
Profitability
Net income was $2.208B, or $10.26 per diluted share, up 46% versus the prior year. Core income rose 44% to $2.160B, or $10.04 per diluted share, with core ROE of 24.9%.
Margins
The consolidated combined ratio improved 6.7 points to 83.6%, and the underlying combined ratio improved 0.6 points to 84.1%. The expense ratio was 29%, slightly higher than a year ago due to profit-sharing and contingent commissions.
Balance Sheet
Operating cash flow was $1.9B in the quarter and over $11B for the trailing 12 months. Net unrealized investment losses narrowed to $2.0B after tax, and adjusted book value per share rose 16% year over year to $168.20.
Key Risks
Management flagged softening national property pricing, particularly for large scheduled property, and a competitive personal auto rate environment. They also acknowledged some disruption from a technology/system conversion, with most issues resolved and work continuing on the remainder.
Outlook
Travelers expects full-year expense ratio around 28.5% and fixed income NII of roughly $840M in Q3 and $870M in Q4. Management remains confident in durable underlying underwriting earnings and continued strong capital returns.
Generated by AI · Q2 2026 results · Not investment advice
🔒
Free Account Required

Create a free Finmagine account to access Finmagine™ Scorecard.

See how this company scores across 5 dimensions — Financial Health, Growth Prospects, Competitive Position, Management Quality, and Valuation — powered by 30+ computed ratios.

Create Free AccountLog In
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Ask AI.

Get 25 expert AI analysis templates — Business KPIs, Comprehensive, Forensic Governance, Peer Comparison, Risk-Reward, Full Research Report, IPO Decoder, Red Flag Detector, and more — ready to paste into ChatGPT, Claude, Gemini, or Perplexity.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Peer Comparison.

Compare this company side-by-side against its sector peers with financial metrics, ratio benchmarking, and relative performance across all key dimensions.

Upgrade to PremiumCreate Free Account
✓ 📞 Earnings Call Transcripts (5 quarters) submit a missing quarter
🔍
🔎 See cross-company document search → ?
📞 Earnings Call Transcripts (5)
Q2 2026 Q2 2026 2026-07-17
Core income reached $2.2 billion in Q2 2026, with a 24.9% core ROE and strong underwriting and investment results across all segments. Premiums and book value rose, while over $1.5 billion was returned to shareholders. Innovation and disciplined capital management support a positive outlook.
Q1 2026 Q1 2026 2026-04-16
Strong Q1 2026 results featured $1.7B core income, robust underwriting, and 9% NII growth. Premiums rose across all segments, with high retention and favorable reserve development. Over $2.2B was returned to shareholders, and a 14% dividend hike was announced.
Q4 2025 Q4 2025 2026-01-21
Q4 and full-year 2025 saw strong underwriting and investment results, with core income up 26% year-over-year and robust returns to shareholders. Strategic investments in AI and technology, disciplined risk management, and favorable reinsurance terms position the company for continued growth and profitability in 2026.
Q3 2025 Q3 2025 2025-10-16
Reported strong Q3 results with $1.9B core income, 22.6% ROE, and improved underwriting across all segments. Premiums and investment income rose, capital returns accelerated, and technology investments remain a priority. Favorable weather and disciplined underwriting supported profitability.
Q2 2025 Q2 2025 2025-07-17
Exceptional Q2 results featured strong underwriting, investment income, and premium growth across all segments, with core ROE at 18.8%. Sale of Canadian business and disciplined capital allocation support continued growth and shareholder returns.
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Catalyst Timeline.

Every result, order win, insider trade, ECS update, earnings-call, and SEC announcement for this company — in one chronological lane.

Upgrade to PremiumCreate Free Account
🔒
Premium Feature

Upgrade to Finmagine Premium to unlock Full Report.

Read the complete Finmagine™ investment research report — comprehensive fundamental analysis, business model assessment, competitive positioning, and investment recommendation.

Upgrade to PremiumCreate Free Account

📊 Analysis Methodology

This comprehensive investment analysis was conducted using The Finmagine™ Stock Analysis & Ranking Methodology, a proprietary framework that systematically evaluates stocks across five critical dimensions: Financial Health, Growth Prospects, Competitive Positioning, Management Quality, and Valuation.

🎯
Discover Our Proven Investment Framework Learn how we analyze and rank stocks using advanced quantitative models, multi-dimensional scoring systems, and dynamic discriminatory ranking techniques that have guided successful investment decisions across market cycles.
📊 Explore The Finmagine™ Methodology

A comprehensive, bias-free framework for analyzing and ranking stocks by Financial Strength, Growth Potential, Competitive Edge, Management Quality, and Value.

Financial Model
Projections are built from each company's audited annual financials (Income Statement, Balance Sheet, Cash Flow) over the last 5 fiscal years. Forward assumptions — revenue growth %, EBITDA margin, D&A (USD millions), interest expense, tax rate, and capex — are AI-generated using historical context and refreshed twice a year: after the December results season and after the September/Q4 results season.

DCF Valuation
Fair Value = Σ(FCFt / (1+WACC)t) + Terminal Value. Terminal Value uses the Gordon Growth Model: FCF5 × (1+g) / (WACC−g). Default WACC: 10% (US risk-free ~4.5%, equity risk premium ~5.5%). Default terminal growth: 3% (long-run US nominal GDP proxy).

CAGR Tracker
Expected 5-year CAGR = (DCF Fair Value / Current Price)1/5 − 1. Assumes fair value is reached in exactly 5 years — a mechanical estimate only.

Data Sources & Limitations
Financial statements sourced from public filings. Prices updated daily. Forward assumptions are AI-generated. All monetary values in USD millions. Non-US ADR companies may have currency conversion inaccuracies. Models are point-in-time and do not update intra-quarter or account for M&A, macro shocks, or extraordinary items.

⚠️ Important Disclaimers — Please read without fail.

Investment Risk:
Investing in securities, including US equities and ETFs, involves inherent risks including the potential loss of principal. All investments are subject to market fluctuations, economic conditions, regulatory changes, and other factors that may affect their value. Past performance is not indicative of future results. This analysis is provided for informational and educational purposes only and should not be construed as investment advice under any circumstances.

No Investment Recommendation:
This analysis does not constitute, nor should it be interpreted as, an offer, solicitation, or recommendation to buy, sell, or hold any securities or financial products. Investors are strongly advised to conduct their own independent research and due diligence and to consult with a licensed financial advisor or an SEC-registered investment adviser before making any investment decisions, taking into account their individual financial situation, risk tolerance, and investment objectives.

Not SEC-Registered:
Finmagine is not registered as an investment adviser with the U.S. Securities and Exchange Commission (SEC) or any state securities authority. Nothing on this platform constitutes investment advice as defined under the Investment Advisers Act of 1940.

Conflict of Interest Disclosure:
The author and/or analyst may currently hold or have previously held positions in the securities discussed. Any such positions are not intended to influence the objectivity or independence of the analysis. This research is produced independently and is not sponsored, endorsed, or commissioned by any company or institution.

Information Sources:
The analysis is based on publicly available information including SEC filings (10-K, 10-Q), annual reports, management commentary, and publicly available financial data. Information is believed to be accurate as of the date of publication but may be subject to change without notice. Readers are encouraged to independently verify all information before acting upon it.

Forward-Looking Statements:
This analysis may contain forward-looking statements, forecasts, or projections that are inherently subject to risks, uncertainties, and assumptions. Actual results may differ materially from those expressed or implied. Finmagine does not undertake any obligation to update such statements in the future.

Limitation of Liability:
The content is provided "as is" without any warranties, express or implied. Finmagine expressly disclaims any liability for errors, omissions, or any losses incurred as a result of reliance on the information provided. Readers assume full responsibility for their investment decisions.